Ryan C. Winger

1.4k total citations
25 papers, 946 citations indexed

About

Ryan C. Winger is a scholar working on Pathology and Forensic Medicine, Neurology and Immunology. According to data from OpenAlex, Ryan C. Winger has authored 25 papers receiving a total of 946 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 8 papers in Neurology and 8 papers in Immunology. Recurrent topics in Ryan C. Winger's work include Multiple Sclerosis Research Studies (9 papers), Peripheral Neuropathies and Disorders (7 papers) and T-cell and B-cell Immunology (6 papers). Ryan C. Winger is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), Peripheral Neuropathies and Disorders (7 papers) and T-cell and B-cell Immunology (6 papers). Ryan C. Winger collaborates with scholars based in United States, Germany and Japan. Ryan C. Winger's co-authors include Michael K. Racke, Amy E. Lovett‐Racke, Yue Liu, Yuhong Yang, David Huss, Haiyan Peng, William A. Müller, Petra D. Cravens, Mireia Guerau‐de‐Arellano and Jeffrey L. Weiner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Ryan C. Winger

24 papers receiving 937 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ryan C. Winger United States	12	450	279	254	175	147	25	946
Michael Friese Germany	6	435 1.0×	105 0.4×	437 1.7×	46 0.3×	186 1.3×	10	925
Andreas Schulte‐Mecklenbeck Germany	19	630 1.4×	270 1.0×	435 1.7×	41 0.2×	282 1.9×	53	1.3k
Holger Babbe Germany	8	707 1.6×	253 0.9×	616 2.4×	38 0.2×	246 1.7×	8	1.3k
Lars Börnsen Denmark	18	487 1.1×	270 1.0×	752 3.0×	67 0.4×	133 0.9×	32	1.3k
Henrike Körner Germany	5	231 0.5×	645 2.3×	102 0.4×	529 3.0×	272 1.9×	6	1.1k
Ingrid Teige Sweden	14	556 1.2×	229 0.8×	102 0.4×	29 0.2×	175 1.2×	40	939
M. Albrecht Germany	9	411 0.9×	155 0.6×	401 1.6×	32 0.2×	122 0.8×	9	873
Marvin M. van Luijn Netherlands	18	571 1.3×	223 0.8×	434 1.7×	52 0.3×	190 1.3×	43	1.1k
Sylvia Eisele United States	10	126 0.3×	426 1.5×	123 0.5×	375 2.1×	113 0.8×	12	867
Wolfgang Brueck Germany	10	276 0.6×	165 0.6×	222 0.9×	24 0.1×	129 0.9×	13	634

Countries citing papers authored by Ryan C. Winger

Since Specialization

Citations

This map shows the geographic impact of Ryan C. Winger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan C. Winger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan C. Winger more than expected).

Fields of papers citing papers by Ryan C. Winger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan C. Winger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan C. Winger. The network helps show where Ryan C. Winger may publish in the future.

Co-authorship network of co-authors of Ryan C. Winger

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan C. Winger. A scholar is included among the top collaborators of Ryan C. Winger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan C. Winger. Ryan C. Winger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kister, Ilya, Amanda L. Piquet, Jinglan Pei, et al.. (2024). Longitudinal study of immunity toSARS‐CoV2in ocrelizumab‐treatedMSpatients up to 2 years afterCOVID‐19 vaccination. Annals of Clinical and Translational Neurology. 11(7). 1750–1764. 2 indexed citations

MacMillan, Erin L., Irene M. Vavasour, Christopher Harp, et al.. (2024). Resolution of glial activation in relapsing and primary progressive MS over 2 years with ocrelizumab: longitudinal MR spectroscopy study. Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition. 1 indexed citations

Dufield, Dawn, Christopher Harp, Akshaya Ramesh, et al.. (2024). Development of an LC-MS/MS Method to Measure Sphingolipids in CSF from Patients with Multiple Sclerosis. Molecular Pharmacology. 105(3). 121–130. 3 indexed citations

Kornilov, Sergey A., Nathan D. Price, Richard Gelinas, et al.. (2024). Multi-Omic characterization of the effects of Ocrelizumab in patients with relapsing-remitting multiple sclerosis. Journal of the Neurological Sciences. 467. 123303–123303. 4 indexed citations

Zivadinov, Robert, Jinglan Pei, David Clayton, et al.. (2023). Evolution of atrophied T2 lesion volume in primary-progressive multiple sclerosis: results from the phase 3 ORATORIO study. Journal of Neurology Neurosurgery & Psychiatry. 95(6). 536–543. 2 indexed citations

Simpson, Haley, Stefan Sillau, Ryan C. Winger, et al.. (2023). Safety and patient experience with at‐home infusion of ocrelizumab for multiple sclerosis. Annals of Clinical and Translational Neurology. 10(4). 579–588. 4 indexed citations

Longbrake, Erin E., Le H. Hua, Ellen M. Mowry, et al.. (2022). The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome. Multiple Sclerosis and Related Disorders. 68. 104143–104143. 9 indexed citations

Simpson, Haley, Stefan Sillau, Ryan C. Winger, et al.. (2022). Evaluating the Impact of Administration of Ocrelizumab via Home Infusion on Safety and Patient Reported Outcomes (P16-4.005). Neurology. 98(18_supplement). 1 indexed citations

Zivadinov, Robert, Jinglan Pei, David Clayton, et al.. (2021). Evolution of Lesions that Shrink or Disappear into Cerebrospinal Fluid (Atrophied T2 Lesion Volume) in Primary-Progressive Multiple Sclerosis: Results from the Phase III ORATORIO Study (107). Neurology. 96(15_supplement). 1 indexed citations

10.

Cohen, Jeffrey A., Amit Bar‐Or, Bruce Cree, et al.. (2019). The FLUENT study design: investigating immune cell subset and neurofilament changes in patients with relapsing multiple sclerosis treated with fingolimod. Multiple Sclerosis Journal - Experimental Translational and Clinical. 5(1). 2453239213–2453239213. 4 indexed citations

11.

Winger, Ryan C., Christopher Harp, Ming‐Yi Chiang, et al.. (2016). Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell–Mediated Central Nervous System Autoimmune Disease. The Journal of Immunology. 196(4). 1443–1448. 25 indexed citations

12.

Watson, Richard L., Jochen Buck, Lonny R. Levin, et al.. (2015). Endothelial CD99 signals through soluble adenylyl cyclase and PKA to regulate leukocyte transendothelial migration. The Journal of Experimental Medicine. 212(7). 1021–1041. 84 indexed citations

13.

Weber, Evan W., et al.. (2015). CD99-like 2 (CD99L2)-deficient mice are defective in the acute inflammatory response. Experimental and Molecular Pathology. 99(3). 455–459. 7 indexed citations

14.

Winger, Ryan C., Jennifer E. Koblinski, Takashi Kanda, Richard M. Ransohoff, & William A. Müller. (2014). Rapid Remodeling of Tight Junctions during Paracellular Diapedesis in a Human Model of the Blood–Brain Barrier. The Journal of Immunology. 193(5). 2427–2437. 85 indexed citations

15.

Guerau‐de‐Arellano, Mireia, Kristen M. Smith, Jakub Godlewski, et al.. (2011). Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity. Brain. 134(12). 3578–3589. 169 indexed citations

16.

Huss, David, Ryan C. Winger, Gina Mavrikis Cox, et al.. (2011). TGF‐β signaling via Smad4 drives IL‐10 production in effector Th1 cells and reduces T‐cell trafficking in EAE. European Journal of Immunology. 41(10). 2987–2996. 39 indexed citations

17.

Huss, David, Ryan C. Winger, Haiyan Peng, et al.. (2010). TGF-β Enhances Effector Th1 Cell Activation but Promotes Self-Regulation via IL-10. The Journal of Immunology. 184(10). 5628–5636. 38 indexed citations

18.

Martin, Maria del Pilar, Petra D. Cravens, Ryan C. Winger, et al.. (2009). Depletion of B Lymphocytes From Cerebral Perivascular Spaces by Rituximab. Archives of Neurology. 66(8). 1016–20. 69 indexed citations

19.

Yang, Yuhong, Yue Liu, Ping Wei, et al.. (2009). Silencing Nogo‐A promotes functional recovery in demyelinating disease. Annals of Neurology. 67(4). 498–507. 63 indexed citations

20.

Yang, Yuhong, Jeffrey L. Weiner, Yue Liu, et al.. (2009). T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. The Journal of Experimental Medicine. 206(7). 1549–1564. 224 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact